Alto Neuroscience, Inc. Contracts & Agreements

24 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Loan Agreement, by and between the Registrant and The Wellcome Trust Limited, dated as of July 24, 2024
Loan Agreements
Alto Neuroscience, Inc.
2024
Form of Amendment to Employment Offer Letter
Employment Agreements
Alto Neuroscience, Inc.
2024
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Alto Neuroscience, Inc.
2024
2024 Employee Stock Purchase Plan
Stock Agreements
Alto Neuroscience, Inc.
2024
Form of RSU Award Grant Notice and Agreement under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Alto Neuroscience, Inc.
2024
Form of Option Grant Notice and Agreement, and Exercise Notice under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Alto Neuroscience, Inc.
2024
2024 Equity Incentive Plan
Bonus & Incentive Agreements
Alto Neuroscience, Inc.
2024
Form of Common Stock Certificate
Stock Agreements
Alto Neuroscience, Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Alto Neuroscience, Inc.
2024
Asset Purchase Agreement, by and between the Registrant and Teva Pharmaceutical Industries, Ltd., dated as of October 4, 2021
Purchase Agreements
Alto Neuroscience, Inc.
2024
Joint Development and License Agreement, by and between the Registrant and MedRx Co., Ltd., dated as of September 25, 2023
License Agreements
Alto Neuroscience, Inc.
2024
Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of November 20, 2023
Investor Rights Agreements
Alto Neuroscience, Inc.
2024
Assignment and Assumption Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021
Assignment Agreements
Alto Neuroscience, Inc.
2024
Asset Transfer Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021
Alto Neuroscience, Inc.
2024
Exclusive License Agreement, by and between Dow Agrosciences LLC and Neuralstem, Inc., dated as of December 1, 2016
License Agreements
Alto Neuroscience, Inc.
2024
Patent and Know-How License Agreement, by and between the Registrant and Cerecor Inc. (k/n/a Avalo Therapeutics, Inc.), dated as of May 28, 2021
License Agreements
Alto Neuroscience, Inc.
2024
License Agreement, by and between the Registrant and Sanofi, dated as of May 18, 2021
License Agreements
Alto Neuroscience, Inc.
2024
Exclusive License Agreement With Equity, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated as of December 6, 2019, as amended...
License Agreements
Alto Neuroscience, Inc.
2024
Loan and Security Agreement, by and among the Registrant, K2 HealthVentures LLC, as a lender, and the other lenders from time to time party thereto, or collectively the Lender, K2...
Loan Agreements
Alto Neuroscience, Inc.
2024
Form of Employment Offer Letter for executive officers
Employment Agreements
Alto Neuroscience, Inc.
2024
Form of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice, and Restricted Award Notice under the 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Alto Neuroscience, Inc.
2024
2019 Equity Incentive Plan
Bonus & Incentive Agreements
Alto Neuroscience, Inc.
2024
Warrant to Purchase Preferred Stock, dated December 16, 2022, issued to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Alto Neuroscience, Inc.
2024
Description of Securities
Alto Neuroscience, Inc.
2024